Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients.
about
Clinical Utility of Fractional exhaled Nitric Oxide (FeNO) as a Biomarker to Predict Severity of Disease and Response to Inhaled Corticosteroid (ICS) in Asthma Patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical Utility of Fractional ...... roid (ICS) in Asthma Patients.
@en
Clinical Utility of Fractional exhaled Nitric Oxide
@nl
type
label
Clinical Utility of Fractional ...... roid (ICS) in Asthma Patients.
@en
Clinical Utility of Fractional exhaled Nitric Oxide
@nl
prefLabel
Clinical Utility of Fractional ...... roid (ICS) in Asthma Patients.
@en
Clinical Utility of Fractional exhaled Nitric Oxide
@nl
P2093
P2860
P356
P1476
Clinical Utility of Fractional ...... roid (ICS) in Asthma Patients.
@en
P2093
Adithan Chandrasekaran
Kadhiravan Tamilarasu
Manju Rajaram
Revathy Neelamegan
Sandhiya Selvarajan
Vinodkumar Saka
P2860
P304
P356
10.7860/JCDR/2016/20656.8950
P577
2016-12-01T00:00:00Z